U.S. flag

An official website of the United States government

NM_001267550.2(TTN):c.835C>T (p.Arg279Trp) AND not specified

Germline classification:
Likely benign (2 submissions)
Last evaluated:
Jun 19, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000219791.7

Allele description [Variation Report for NM_001267550.2(TTN):c.835C>T (p.Arg279Trp)]

NM_001267550.2(TTN):c.835C>T (p.Arg279Trp)

Gene:
TTN:titin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q31.2
Genomic location:
Preferred name:
NM_001267550.2(TTN):c.835C>T (p.Arg279Trp)
Other names:
p.R279W:CGG>TGG
HGVS:
  • NC_000002.12:g.178799566G>A
  • NG_011618.3:g.36237C>T
  • NM_001256850.1:c.835C>T
  • NM_001267550.2:c.835C>TMANE SELECT
  • NM_003319.4:c.835C>T
  • NM_133378.4:c.835C>T
  • NM_133379.5:c.835C>T
  • NM_133432.3:c.835C>T
  • NM_133437.4:c.835C>T
  • NP_001243779.1:p.Arg279Trp
  • NP_001254479.2:p.Arg279Trp
  • NP_003310.4:p.Arg279Trp
  • NP_596869.4:p.Arg279Trp
  • NP_596870.2:p.Arg279Trp
  • NP_597676.3:p.Arg279Trp
  • NP_597681.4:p.Arg279Trp
  • LRG_391t1:c.835C>T
  • LRG_391:g.36237C>T
  • NC_000002.11:g.179664293G>A
  • NM_001267550.1:c.835C>T
  • Q8WZ42:p.Arg279Trp
Protein change:
R279W; ARG279TRP
Links:
UniProtKB: Q8WZ42#VAR_026634; OMIM: 188840.0011; dbSNP: rs138060032
NCBI 1000 Genomes Browser:
rs138060032
Molecular consequence:
  • NM_001256850.1:c.835C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001267550.2:c.835C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_003319.4:c.835C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133378.4:c.835C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133379.5:c.835C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133432.3:c.835C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133437.4:c.835C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000272796Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Likely benign
(Apr 9, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004021283Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely benign
(Jun 19, 2023)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided11not providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy.

van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP, Hilfiker-Kleiner D, Bollen IA, Sliwa K, Alders M, Almomani R, van Langen IM, van der Meer P, Sinke RJ, van der Velden J, Van Veldhuisen DJ, van Tintelen JP, Jongbloed JD.

Eur Heart J. 2014 Aug 21;35(32):2165-73. doi: 10.1093/eurheartj/ehu050. Epub 2014 Feb 20.

PubMed [citation]
PMID:
24558114
See all PubMed Citations (9)

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000272796.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

proposed classification - variant undergoing re-assessment, contact laboratory

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided1not provided1not provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004021283.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

Variant summary: TTN c.835C>T (p.Arg279Trp) results in a non-conservative amino acid change located in the Z-disk region of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00019 in 282792 control chromosomes, predominantly at a frequency of 0.00036 within the Non-Finnish European subpopulation in the gnomAD database. This frequency is approximately equal to the estimated maximal expected allele frequency for a pathogenic variant in TTN causing Dilated Cardiomyopathy (0.00039), suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. c.835C>T has been reported in the literature in multiple individuals affected with TTN-related conditions without strong evidence for causality (e.g., Lange_2005, Campuzan_2015, Sanchez_2016, van Spaendonck-Zwart_2014). At-least two co-occurrences with other pathogenic variant(s) have been reported in cis with this variant (TTN c.87491C>T, p.Pro29164Leu, Lange_2005; c.69086_69095del10, p.Arg23029ThrfsX9, van Spaendonck-Zwart_2014), providing supporting evidence for a benign role. Two publications report experimental evidence evaluating an impact on protein function, demonstrating reduced binding to nbd1 in mutant cells (Lange_2005, Chaveau_2014). However, neither study provides quantitative data indicating the strength of the effect. The following publications have been ascertained in the context of this evaluation (PMID: 26516846, 24105469, 24569025, 24578547, 27930701, 20708934, 24558114, 15802564, 24271327, 24231549). Eight submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Six submitters classified the variant as a variant of uncertain significance, and two classified it as likely benign. Based on the evidence outlined above, the variant was classified as likely benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024